Ashot S. Harutyunyan
McGill Genome Centre(CA)McGill University(CA)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms(2013)1,952 cited
- → A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease(2011)898 cited
- → JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes(2013)576 cited
- → The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape(2019)549 cited
- → H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis(2019)379 cited
- → A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms(2009)354 cited
- → H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas(2017)263 cited
- → Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas(2019)254 cited
- → p53 Lesions in Leukemic Transformation(2011)204 cited
- → Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis(2020)187 cited